Picture of AtriCure logo

ATRC AtriCure News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapFalling Star

AtriCure Inc expected to post a loss of 29  cents a share - Earnings Preview

* AtriCure Inc  ATRC.OQ   ATRC.O  is expected to show a rise
in
quarterly revenue when it reports  results on August 2. 
    * The Mason Ohio-based  company is expected to report  a
11.6% increase in revenue to $79.672 million from $71.38 million
a year ago, according to the mean estimate from 7 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for AtriCure Inc is for
a
loss of 29 cents per share. For the same quarter last year, the
company reported a loss of 36 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for AtriCure
Inc is
$72​, above​ its last closing price of $48.75. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2022  -0.31       -0.32      -0.33     Missed  -3.2
 Dec. 31 2022  -0.29       -0.29      -0.30     Missed  -3.4
 Sep. 30 2021  -0.33       -0.32      2.11      Beat    750​
 Jun. 30 2021  -0.34       -0.33      -0.36     Missed  -7.5
 ​​Mar.        -0.37       -0.37      -0.38     Missed  -3.5
 31 2021                                                
 Dec. 31 2020  -0.27       -0.28      -0.28     Met     0.6​
 Sep. 30 2020  -0.32       -0.34      -0.11     Beat    67.6
 Jun. 30 2020  -0.56       -0.57      -0.20     Beat    64.9
 This summary was machine generated July 29 at 20:11 GMT.  All
figures in US dollars  unless otherwise stated

Recent news on AtriCure

See all news